Using Big Data for Personalized Medicine Could Mean Big Business
Thursday, June 25, 2015
A recent Washington Post article about the big business of personalized medicine further echoed what attendees of the Virginia Bio THRiVE 2015 conference witnessed through the Governor's Forum on Bio and Big Data/Analytics.
The Post referenced that health-care providers are exploring the new model of treatment which involves the study of the human genome to provide personalized care. That new model creates a problem with which many in government are familiar: analyzing an overwhelming amount of data. Their experience is putting government contractors in a key position to grow through this new industry.
Collaboration across the public and private sectors will be critical in wading through the flood of healthcare data being made available. Companies such as Northrup Grumman are partnering with universities to study electronic health records and gain perspectives for diseases impacting a large percentage of the population.
Some health systems are developing new ways to provide top care. Inova Hospital System is opening a 117-acre research campus that will be dedicated to personalized medicine and to combating cancer. Organization executives have an interest in partnering with other companies in the region as well.
More discussion will continue on how to best address this growing data source.
Click here for the full Washington Post article.